Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Eric Johnson

Undersea and Hyperbaric Medicine Bozeman, MT Medical Doctor

NPI 1699718023 CMS profile 167780

935 Highland Blvd Ste 2180, Bozeman, MT 59715

Open in the dashboard

General payments

$7,362

20 records reported · program years 2019–2023

Research payments

$15,000

Paid to them · 1 record reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Eric Johnson of Bozeman, MT is reported in the CMS Open Payments database as having received $7,362 across 20 general payments and $15,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $128 1
2020 General $98 3
2019 General $7,136 16
2019 Research $15,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Johnson
  • Undersea and Hyperbaric Medicine median
  • Middle half of Undersea and Hyperbaric Medicine
  • National median

In program year 2025, general payments to Eric Johnson were reported at $0. Among 65 Undersea and Hyperbaric Medicine profiles paid that year, the median was $153 and the middle half received between $68 and $340.

Show as a table
Year Eric Johnson Undersea and Hyperbaric Medicine median Middle half National median
2019 $7,136 $162 $85–$376 $163
2020 $98 $111 $46–$307 $114
2021 $0 $154 $50–$306 $132
2022 $0 $122 $40–$378 $149
2023 $128 $145 $52–$410 $160
2024 $0 $146 $80–$316 $164
2025 $0 $153 $68–$340 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Smith+Nephew, Inc. $7,230 17 payments
  2. Osiris Therapeutics Inc. $133 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,000 2 payments
  2. Food and Beverage $848 15 payments
  3. Travel and Lodging $514 3 payments
Products named General payments · program years 2019–2023
  1. GRAFIX $6,478 12 payments
  2. Stravix Other Advanced Wound Management $6,403 10 payments
  3. GrafixPL $5,889 7 payments
  4. Grafix PL PRIME $1,052 5 payments
  5. GRAFIX XC $579 2 payments
  6. Grafix PRIME $547 2 payments
  7. Grafix CORE $500 1 payment
  8. GRAFIX PL $128 1 payment
  9. STRAVIX Extremities & Limb Restoration $47 1 payment
  10. PICO 7 Single Use Negative Pressure Wound Therapy $24 1 payment
  11. Other $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Smith+Nephew, Inc. $15,000 1 payment

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record